Contents
Contents
Pharmacy false prior authorization fraud uses false prescriber signatures, contact details or clinical information to get a prescription approved and paid. If you handle those requests, you may know whose fax number went in the physician’s box, who supplied the treatment history and whether the doctor authorized the signature.
Pharmacy employees filled in answers presented as the physicians’ own. Solera’s criminal admissions and the civil settlement with Benzer Pharmacy Holding, a Tampa specialty pharmacy operator, show that practice.
The transaction passes through several hands. The prescriber orders the medicine. The pharmacy dispenses it and sends the claim to a processor. The health plan makes the coverage decision, sometimes through a delegated entity. In Medicare Part D, the prescriber’s supporting statement, the pharmacy’s electronic rejection and the plan’s coverage decision are separate records.
Pharmacy staff impersonate a prescriber when they submit answers as though they came from the physician’s office, including signing without the physician’s permission. Under its deferred prosecution agreement, Solera admitted that pharmacy staff completed authorizations in physicians’ place, sometimes signed without permission, substituted pharmacy contact details and supplied false clinical information, according to the Justice Department’s July 2022 account of the company’s deferred prosecution agreement.
The signature and contact fields did different work. The signature presented the request as the physician’s. The substituted contact details put the pharmacy in the path of communications about that request. The clinical answers supplied the reason to approve coverage. A healthcare employee who watched those forms being filled in may know who supplied the answers and authorized the signature. Solera and its chief executive also agreed to a $1.31 million civil settlement.
Benzer admitted both impersonating physicians and submitting false clinical answers to obtain payment for a more expensive drug. Its May 2024 civil settlement agreement sets out admissions by Benzer Pharmacy Holding.
Evzio was an injectable form of naloxone used in an opioid overdose emergency. The agreement describes it as the highest-priced version of naloxone on the market during the period at issue. Insurers frequently required prior authorization before covering it. Getting the request approved was therefore a commercial question as well as a clinical one: it helped determine whether the pharmacy could get paid for that product.
Benzer employed patient assistance specialists who completed and submitted prior authorization requests. Government insurers, including Medicare Part D plans, often required clinical information directly from the prescribing physician’s office.
The specialists completed Evzio forms in the physicians’ place, including instances of signing without the physician’s authorization. Benzer submitted the forms as if it were the physician. On dozens of requests, it entered its own fax numbers where the forms asked for the prescribing physician’s fax number. Benzer admitted the purpose: insurers would contact the pharmacy instead of the listed physician about the request.
That fax box was doing more than identifying a destination. It directed follow-up questions back to the business submitting the answers. An insider who knows which number belonged to the pharmacy can explain something the completed form conceals from its reader.
Benzer also admitted falsely stating on dozens of forms that patients had tried and failed both Narcan and naloxone. The agreement gives another concrete example:
Furthermore, the Defendants falsely stated on Evzio prior authorization request forms that patients had shaky hands or nasal problems.
Benzer Pharmacy Holding settlement agreement, admitted facts, May 2024
These statements described the patient’s treatment history and physical condition. The pharmacy wrote the medical reason to pay for the drug it was selling. We call that making the facts fit the sale. The person entering those answers may know whether they came from the physician’s office or from instructions inside the pharmacy.
Benzer admitted that government insurers approved false Evzio authorization requests. It also admitted understanding that insurers would not have authorized and paid for the prescriptions had they known the forms contained false information. Benzer also admitted failing to adequately oversee and train the staff responsible for these requests.
Benzer agreed to pay $1,018,000 to the United States in the civil settlement. The case began with a whistleblower’s qui tam case, and the agreement provides a 28% whistleblower share of each payment the government receives.
A diagnosis certification concerns whether the prescription meets the payer’s clinical and documentation requirements. Prescriber impersonation concerns who supplied the answers: pharmacy staff presenting themselves as the doctor’s office.
In its November 2025 settlement announcement, the Justice Department reported that CVS paid $18,282,280 under its civil agreement to resolve allegations that it falsely certified compliance with Medi-Cal Code 1 diagnosis and documentation restrictions. The government alleged that CVS made those certifications electronically. The department also explained that payment outside an approved diagnosis could be sought through a separate authorization with supporting justification.
For CVS, the question was whether the pharmacy had the clinical support and records for what it certified to Medi-Cal. For Benzer, the admissions included pharmacy employees presenting themselves as the physician’s office.
Kaleo agreed to pay $12.7 million in its 2021 civil settlement. The government’s allegations against the Evzio manufacturer included directing prescriptions to preferred pharmacies.
The alleged manufacturer program helps explain how prescriptions reached pharmacies. Examining the pharmacy’s authorization then means identifying who completed the request, whose clinical information it contained and what went to the insurer. We follow the prescription across that handoff to understand the referral and the authorization.
An insider can connect the authorization’s contents to its author, the prescriber’s actual approval and the resulting claim. The useful detail may be a changed fax number, a treatment history added to a resubmission or an instruction to sign for a physician. We work through the versions and the people involved with you.
The prescription, authorization and claim each hold a different part of the transaction. The prescription identifies the order. The authorization carries the clinical answers and the claimed source of those answers. The claim carries the drug, quantity, prescriber identifier and billing information.
New York’s pharmacy transaction guide distinguishes billing, reversal and rebill transactions and separately identifies the prescription reference and prescriber. The payment history can therefore include a rejected claim, revised billing and a later payment.
When a denial is followed by a changed authorization and a paid claim, we examine what changed between submissions and who supplied it. Fax or portal history can help identify the author, and the clinical record can show where the answer came from. Together, they can show how an invented clinical fact reached a health care payment.
A pharmacy employee may understand the authorization process. A manufacturer employee may understand how prescriptions reached the pharmacy: a former manufacturer employee brought the related Evzio whistleblower cases. You can start the conversation with what you personally saw and the records you can describe. We work through the evidence with you. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know how your pharmacy turned prescriber information into an approval, speak with our whistleblower experts about the requests you handled. We work beside you to connect the false answers, the people directing them and the government payments, and build your strongest pharmacy fraud whistleblower case. We bring in pharmacy fraud whistleblower lawyers who understand authorization and billing cases, and stay with you through the process.